Navigation Links
ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Date:9/6/2011

ing neurological and muscle destruction and degradation of renal function, as well as numerous negative cognitive, behavioral and neurological effects. If left untreated, seizures can lead to status epilepticus (SE) and patients may require hospitalization and intensive care.  

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options, including C1 esterase inhibitor deficiency, treatment of seizures in children and adolescents, and C. difficile infection (CDI).  Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve.  ViroPharma's commercial products address diseases including hereditary angioedema (HAE), CDI and treatment of seizures in children and adolescents; for full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com. 

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
2. Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
3. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
4. Enox Biopharma, Inc. Will Be Granted its Foundation Patent
5. Winner Medical Granted the COTTON USA Mark
6. Patent Granted for Simbionix Procedure Rehearsal Studio™
7. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
8. China Botanic Pharmaceutical Granted China Patent for Siberian Ginseng Extraction Process
9. ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardts Disease
10. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
11. Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Reimbursement Scenario for Medical Devices in ...   Changing Regulatory ... the US Market   ...
(Date:5/21/2013)... Calif. , May 21, 2013 STAAR ... developer, manufacturer and marketer of minimally invasive ophthalmic products, ... investor conferences to review the Company,s recent financial results ... STAAR Surgical will present at the 38 th ... Boston at the Westin Waterfront Hotel ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4STAAR Surgical To Present At Upcoming Investor Conferences 2
... , TORONTO, Nov. 30 The Special Committee of Independent ... and JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, ... have entered into a settlement agreement in respect of the ... settlement provides among other things that: , until March ...
... , NEW YORK, Nov. 30 ... available in its catalogue: , Operating Tables - ... , Operating tables are primarily used to keep the ... to conduct the surgical procedure and, if necessary, enable ...
Cached Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3Reportlinker Adds Operating Tables - A World Market Review 2Reportlinker Adds Operating Tables - A World Market Review 3Reportlinker Adds Operating Tables - A World Market Review 4Reportlinker Adds Operating Tables - A World Market Review 5
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... may be at increased risk of suffering depression after ... researchers hope they can use the findings to develop ... who are vulnerable to postpartum depression, which affects around ... in the May 21 issue of the journal ...
(Date:5/21/2013)... 2013 Puroast® Low Acid Coffee has ... its Chairman of the Board. , Among ... & Johnson during his more than 30-year career was ... Committee, Worldwide Chairman of Consumer Pharmaceuticals & Nutritionals and ... to develop and build the market for such brands ...
(Date:5/21/2013)... tumor cells that uses a modified poliovirus is showing ... proper dose level, researchers at Duke Cancer Institute report. ... an ongoing phase 1 study, capitalizes on the discovery ... work like magnets drawing the poliovirus, which then infects ... known as PVSRIPO, uses an engineered form of the ...
(Date:5/21/2013)... Chicago, IL (PRWEB) May 21, 2013 ... business process integration solutions, today announced it is the ... by analyst firm 451 Research. The report, “Adeptia Bets ... in-depth review of the company, its strategy, products, pricing, ... are in need of a framework for integration and ...
(Date:5/21/2013)... By Serena Gordon HealthDay Reporter , , TUESDAY, ... every aspect of life, but some of the changes ... for those with diabetes. New research has found ... than a 40 percent higher risk of having a ... in the hospital compared to people with diabetes who ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Former Johnson & Johnson Executive Brian Perkins Named Chairman of Puroast® Coffee 2Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3
... Medarex, Inc.,(Nasdaq: MEDX ) is scheduled to host ... Annual Meeting of the American Society of Clinical,Oncology (ASCO) ... at 8:00 a.m. Eastern Time / 7:00 a.m. Central ... be joined by Jedd D. Wolchok, M.D.,Ph.D., Director of ...
... Children Not Meeting Daily Physical,Activity Recommendations, INDIANAPOLIS, ... care homes are unlikely to be meeting physical ... released today,at the 55th Annual Meeting of the ... operated family child care homes, as the second,largest ...
... KV Expects Filings To Be Completed Within Automatic Form 10-K Extension ... ... ST. LOUIS, May 30 KV Pharmaceutical Company,(NYSE: KVa/KVb), a ... products and generic/non-branded prescription pharmaceuticals,announced today that it expects to complete ...
... new University of,Detroit Mercy School of Dentistry and Clinic ... from 9 a.m. to 1 p.m. on the new ... screenings for community,members, as well as oral health awareness ... of the School of Dentistry,s 75th,Anniversary., Over 211,000 ...
... 2008, New YorkThe number of uninsured young adults in the ... 13.3 million in 2005making the 19-to-29 age group one of ... insurance. According to a newly updated report from The Commonwealth ... attend college and 34 percent of college graduates will spend ...
... of Michigan,ranked among the nation,s top 30 hospitals ... America,s Best Children,s Hospitals. This publication,ranked each pediatric ... neonatal care, neurology and neurosurgery, respiratory,disorders, and general ... neurology and neurosurgery., U.S. News uses several ...
Cached Medicine News:Health News:Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO 2Health News:Preschoolers in Family Child Care Homes Need More Activity 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 3Health News:UDM School of Dentistry to Host Community Open House 2Health News:Young adults at risk: 13.7 million lack health insurance coverage 2Health News:Young adults at risk: 13.7 million lack health insurance coverage 3Health News:DMC Children's Hospital of Michigan Ranked Among America's Best 2
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
These flexible stone retrieval devices are reusable, 3 Fr in diameter, with a working length of either 60 cm or 115 cm...
... of dexterity in stone retrieval. SurLok ... and release easily, while the unique ... A three- or four-pronged hook design ... retrieval. These graspers securely attach to ...
For rigid cystoscopes and rigid-, and semi-rigid ureteroscopes, these forceps have an integral handle design and a diameter of 5 Fr with a working length of 58 cm....
Medicine Products: